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The 20th century is likely to be remembered as a period during which a rise 
and fall of cardiovascular disease was experienced in North America and 
Western Europe. In most of the countries in these regions, the incidence of 
stroke and, then, of ischemic heart disease increased slowly but steadily 
from the beginning of the 20th century, then reached a peak in the sixties or 
seventies, and eventually started to decrease. In almost all Western European 
countries, the incidence rates are currently still declining, with a shift of 
cardiovascular deaths towards higher age. Thus, the absolute number of 
cases  tends  to  remain  constant  (or  even  to  increase)  because  of  the 
counteracting effect of population ageing. 
In the early 1970s, Abdul Omran offered the clever paradigm of epi-
demiological transition to describe the intricate changes of demography, 
socioeconomic environment, lifestyles and health services leading to the 
predominance of chronic and degenerative diseases.1 Although not fully 
illuminating the causal pathways explaining the epidemiological changes 
of  cardiovascular  disease,  Omran’s  paradigm  foresaw  what  sorts  of 
challenges would predominate in the future. In other words, the paradigm 
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of  epidemiological  transition  opened  up  a  new  area  of  public  health, 
illustrated by the globalization of cardiovascular disease.
Sadly, it took a long time to fully draw conclusions from Omran’s vision 
in terms of public health priorities and strategies, especially in low and 
middle income countries. In fact, arguably the first large scale endorsement 
of health transition at the global level took place only recently in September 
2011 at the United Nations High-level Meeting on Non-Communicable 
Diseases Prevention and Control held in New York,2 of which cardiovascular 
disease is an important part. This was exactly 40 years after the publication 
of Omran’s paper. But the evidence is overwhelming: in 2005, the estimated 
losses in national income from heart disease, stroke and diabetes (reported 
in  international  dollars)  were  $18  billion  in  China,  $11  billion  in  the 
Russian Federation, $9 billion in India and $3 billion dollars in Brazil.3 
However, evidence abounds that prevention of cardiovascular disease 
can be effective at a population level. In Finland, a community and national 
intervention aimed at changing behaviors resulted in a reduction of coronary 
deaths by 85 percent as well as a reduction in all-cause mortality, a feat 
described with hindsight by Oppenheimer, Blackburn and Puska in this 
issue.4 Importantly, while this reduction was greater in younger age groups 
(–96%  in  men  35-44  years),  it  remained  significant  in  all  ages  of  the 
population (–69% in men 65-79 years), signaling that it is never too late for 
prevention. In Poland, after the government ended the subsidy on highly-
saturated meats and fats and encouraged the consumption of vegetables, 
coronary heart disease mortality rates fell by 25 percent in the following 
five years, even without noticeable improvement in the health care system.5,6 
Further dramatic demonstration of the effect of prevention is provided from 
the town of Helena in the state of Montana, United States where population 
acute coronary syndromes decrease by 40 percent in six months after a 
smoking ban, and returned to previous levels when the law was rescinded.7 
The fruits of prevention are thus already harvested in just months and years, 
and not simply decades after implementation, a point worth making to 
populations, public health decision-makers and politicians alike.8 
Moreover, these effects are demonstrable in populations as disparate as 
Cuba  and  the  US.  The  economic  crisis  of  1991-1995  in  Cuba  led  to 
increased  physical  activity  from  30  percent  to  67  percent  (due  to  fuel 
shortages for buses), resulting in a decreased prevalence of obesity from 14 
percent to seven percent and a fall of coronary deaths within a year and a 
39 percent decline by 2002.9 In the vastly different US population, with a 
decidedly distinct health care system, a nationwide analysis demonstrated 
that primary and secondary prevention still explain a higher proportion of 
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with 44 percent of the decline attributed to changes in risk factors, despite 
the increase in the prevalence of obesity.10 Therefore, prevention works for 
all age-groups, in populations as diverse as those found in Cuba, Poland, 
Finland and the US, and yields near-term results in cardiovascular disease.
This prevention has to be multifaceted. In this issue of the Journal, we 
have  aimed  to  provide  both  first-hand  accounts  of  what  has  worked 
(Luepker on WHO MONICA11; Oppenheimer, Blackburn and Puska on the 
journey from Framingham to North Karelia4) as well as a window on new 
challenges facing our transitioning world (Bovet and Paccaud on low and 
middle-income  countries12;  Pajak  and  Kozela  on  Central  and  Eastern 
Europe13;  Petrukhin  and  Lunina  on  Russia14),  while  addressing  novel 
concepts  (Jacobs,  Tapsell  and  Temple  on  food  synergy15),  approaches 
(Lovasi,  Grady  and  Rundle  on  walkability  and  health16),  controversies 
(Bochud, et al. on dietary salt intake17), reasoned regulatory arguments (Jha 
on avoidable deaths from smoking18) or pertinent reflections (Bayer and 
Feldman on the limits of public health achievements for tobacco control19; 
Lang, et al. on social determinants20) on our path to prevention. Although 
naturally  mentioned  throughout,  we  do  not  specifically  address  stroke, 
which we aim to do in a subsequent relevant issue. We hope that this issue 
of Public Health Reviews will be helpful to practitioners of public health, 
researchers and public policy decision-makers alike, as the enclosed articles 
offer  a  mix  of  fundamental  issues  and  practical  aspects  related  to 
cardiovascular  health.  Quite  fittingly,  this  issue  begins  with  career 
reflections from Daan Kromhout21 and Salim Yusuf,22 two distinguished 
cardiovascular researchers embodying these efforts from vastly different 
vantage points yet unified in a common goal, for which we are grateful. 
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